Interleukin-12, antagonists & inhibitors
- Name
- Interleukin-12, antagonists & inhibitors
- Accession Number
- DBCAT005146
- Description
Not Available
- Drugs
Drug Drug Description Edodekin alfa Edodekin alfa is under investigation in clinical trial NCT01468896 (Cetuximab and Recombinant Interleukin-12 in Treating Patients With Squamous Cell Carcinoma of the Head and Neck That Is Recurrent, Metastatic, or... - Drugs & Drug Targets
Drug Target Type